Are your patients
with metastatic
castrate-resistant
prostate cancer
eligible for a Phase III
clinical trial?

Now enrolling patients
with metastatic
castrate-resistant
prostate cancer

Learn more about
a Phase III clinical
trial in prostate
cancer

Now Enrolling IPATential150
BioOncology Genentech

© 2017 Genentech USA, Inc. All rights reserved. BIO/062717/0106